Legislation Details

File #: 26-2347    Version: 1 Name: RECOGNIZING BLOOD CANCER AND SICKLE CELL AWARENESS MONTH IN COOK COUNTY
Type: Consent Calendar Resolution Status: Agenda Ready
File created: 9/16/2026 In control: Board of Commissioners
On agenda: 9/24/2026 Final action:
Title: PROPOSED RESOLUTION RECOGNIZING BLOOD CANCER AND SICKLE CELL AWARENESS MONTH IN COOK COUNTY WHEREAS, the month of September is National Blood Cancer and Sickle Cell Awareness Month, a month-long initiative designated by Congress to help focus attention on the need for research and treatment of blood cancer and sickle cell diseases; and WHEREAS, Sickle cell disease (SCD) is the most common inherited blood disorder in the United States, in which red blood cells may become sickle-shaped and harden. For a baby to be born with sickle cell disease, both parents must carry a sickle cell trait or gene. Sickle cell disease is not contagious, and there is no universal cure; and WHEREAS, about 1 in 13 African Americans carry the sickle cell trait, and many do not know they have it; an estimated 100,000 people in the U.S. have SCD, with approximately 2,000 babies born with SCD annually in the United States; and WHEREAS, people of many ethnic backgrounds can have SCD, but it disproportionately...
Sponsors: DONNA MILLER
Date Ver.Action ByMotionResultAction DetailsMeeting DetailsVideo
No records to display.
title
PROPOSED RESOLUTION

RECOGNIZING BLOOD CANCER AND SICKLE CELL AWARENESS MONTH IN COOK COUNTY

WHEREAS, the month of September is National Blood Cancer and Sickle Cell Awareness Month, a month-long initiative designated by Congress to help focus attention on the need for research and treatment of blood cancer and sickle cell diseases; and

WHEREAS, Sickle cell disease (SCD) is the most common inherited blood disorder in the United States, in which red blood cells may become sickle-shaped and harden. For a baby to be born with sickle cell disease, both parents must carry a sickle cell trait or gene. Sickle cell disease is not contagious, and there is no universal cure; and

WHEREAS, about 1 in 13 African Americans carry the sickle cell trait, and many do not know they have it; an estimated 100,000 people in the U.S. have SCD, with approximately 2,000 babies born with SCD annually in the United States; and

WHEREAS, people of many ethnic backgrounds can have SCD, but it disproportionately affects Black and Brown Americans, with more than 90% of U.S. cases occurring in non-Hispanic Black or African American individuals, and an estimated 3%–9% occurring in Hispanic or Latino individuals; and

WHEREAS, sickle cell disease leads to complications including chronic, severe, and unpredictable pain, anemia, frequent infections, swelling in the extremities, fatigue, and delayed growth, and was identified as an underlying medical condition associated with increased risk of severe illness from COVID-19, including hospitalization, ICU admission, intubation or mechanical ventilation, or death; and

WHEREAS, this national focus reinforces the National Institutes of Health's (NIH) continued support of SCD research, education, and capacity building, including the "Cure Sickle Cell Initiative" to accelerate safe, effective, and scalable gene therapies to cure the disease; and

WHEREAS, because of advances and medical breakthroughs in genetic therapies and research, new curative...

Click here for full text